KRYS icon

Krystal Biotech

137 hedge funds and large institutions have $1.36B invested in Krystal Biotech in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 46 increasing their positions, 52 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

0% less capital invested

Capital invested by funds: $1.37B → $1.36B (-$961K)

0.63% less ownership

Funds ownership: 81.7%81.07% (-0.63%)

12% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 52

Holders
137
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$9.2M
Puts
$3.87M
Net Calls
Net Calls Change

Top Sellers

1 -$9.59M
2 -$8.03M
3 -$4.92M
4
Jennison Associates
Jennison Associates
New York
-$4.54M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$4.02M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$1.67M
52
$1.56M
53
$1.48M
54
$1.42M
55
$1.4M
56
$1.38M
57
$1.24M
58
$1.24M
59
$1.13M
60
$1.12M
61
$1.07M
62
$1.04M
63
$1.04M
64
$999K
65
$998K
66
$990K
67
$970K
68
$936K
69
$919K
70
$880K
71
$857K
72
$803K
73
$718K
74
$674K
75
$644K